e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction
Annelore Sacreas, Jean-Luc Taupin, Marie-Paule Emonds, Liesbeth Daniëls, Dirk E. Van Raemdonck, Robin Vos, Geert M. Verleden, Bart M. Vanaudenaerde, Antoine Roux, Stijn E. Verleden
Source:
Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019
Journal Issue:
November
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Annelore Sacreas, Jean-Luc Taupin, Marie-Paule Emonds, Liesbeth Daniëls, Dirk E. Van Raemdonck, Robin Vos, Geert M. Verleden, Bart M. Vanaudenaerde, Antoine Roux, Stijn E. Verleden. Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction. Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Intragraft donor-specific antibodies and lung transplantation
Source: Eur Respir J, 54 (5) 1901937; 10.1183/13993003.01937-2019
Year: 2019
Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation
Source: Eur Respir J, 50 (5) 1701248; 10.1183/13993003.01248-2017
Year: 2017
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome
Source: Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017
Year: 2018
Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007
The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012
T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006
A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome
Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020
Year: 2021
Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001
Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD)
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
TNFα-308 polymorphism associates with acute lung allograft rejection
Source: Eur Respir J 2005; 26: Suppl. 49, 175s
Year: 2005
Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021
Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004
Evidence of indirect allorecognition of HLA /non-HLA antigens expressed by bronchial epithelial cells from lung transplant recipients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Significance of anti-HLA immunization in lung transplantation
Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations
Year: 2011
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept